How mushrooms are taking over the healthcare industry, and how investors can profit off of this. First we will talk about how they are being used as treatments for mental health conditions. And then we will talk about how regular, non psychedelic mushrooms are being used to promote healthy lifestyles, and perhaps even lengthen lifespans and increase quality of life.
The psychedelic craze has overshadowed another important facet of mushrooms and the Shroom Boom.
The health benefits and investing opportunities of non-psychedelic mushrooms.
Fungi like Lion’s Mane, Chaga and reishi have a variety of health benefits, and have recently been labelled as superfoods.
For example, Reishi mushrooms, which have been “revered in Asian societies for thousands of years”, have antibacterial, antiviral, and anti-fungal characteristics, and is high in proteins and vitamins.
While this is great news for you health, and I personally incorporate mushroom extracts into my diet, on this channel we also focuses on investing.
According to the Grand View Research Corporation, the global mushroom market, not including the psychedelic variety, is set to grow to an eye watering $50 billion annually by 2025.
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
The Psychedelic Investor was compensated $1,000 by Future Money Trends for the having the interview with PlantX CEO. James (The Psychedelic Investor) does not own a position in PlantX and will not open one for at least 30 days after publication of this video.
#ShroomBoom #PlantX #PsychedelicStocks
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.